Abstract-Glioma histologies are the primary factor in prognostic estimates and are used in determining the proper course of treatment. Furthermore, due to the sensitivity of cranial environments, real-time tumor-cell classification and boundary detection can aid in the precision and completeness of tumor resection. A recent improvement to mass spectrometry known as desorption electrospray ionization operates in an ambient environment without the application of a preparation compound. This allows for a real-time acquisition of mass spectra during surgeries and other live operations. In this paper, we present a framework using sparse kernel machines to determine a glioma sample's histopathological subtype by analyzing its chemical composition acquired by desorption electrospray ionization mass spectrometry.
tumor cells are from the original cells [4] . The American Joint Commission on Cancer grades most tumors on a scale from G1 through G4, where G1 tumors are composed of cells similar to the original tissue, and G4 cells are the most differentiated [4] . These histopathological categories are the primary factors used in determining the prognosis of the tumor and planning treatment [4] , [7] .
Due to the sensitive nature of the cranial environment, the identification of cancerous tissue is of utmost importance [8] . Histopathological classification is currently performed by sending a resected sample for evaluation by an expert [9] . This process is inefficient during a neural surgery where accurate tumor classification and boundary detection are crucial.
Numerous techniques exist for identifying and analyzing cancerous cells. A well-established technique known as mass spectrometry (MS) is often used for analysis of complex proteins and lipids [10] , [11] . MS is appropriate for this application due to brain matter being primarily composed of lipids and proteins [12] . It has been shown that certain disorders and conditions cause a measurable change in the composition of these molecules [11] . Specifically, gliomas have been shown to exhibit differences in lipid composition compared to healthy glial tissue [12] , [13] . MS is a powerful tool to measure this change, where it is capable of identifying the molecular composition of a given sample. Specifically, the sample molecules are ionized into gas and identified using a property of the ions known as the massto-charge ratio (m/z) [10] . MS is specifically advantageous in a clinical setting due to multiple reasons. First, it has a high sensitivity and provides a large amount of chemical information. In addition, the administration of contrast agents can be avoided [8] .
Traditional MS methods, including matrix-assisted laser desorption/ionization (MALDI) [14] , [15] , require sample preparation, which introduces a significant delay between the sample resection and the mass spectrum acquisition for clinical applications. A recent improvement to MS known as desorption electrospray ionization mass spectrometry (DESI-MS) involves ionization of molecules in an ambient environment without the application of a preparation compound [16] . This allows for a real-time acquisition of mass spectra during surgeries and other live operations.
Prior work has shown that mass spectrometry can be successfully used as a technique for cancer detection [17] . Furthermore, mass data from DESI-MS has been used to successfully diagnose bladder carcinomas [11] . Glioma subtype classification has been explored using gene expression data [18] . In [9] , the authors present a preliminary study for classification of glioma subtypes using mass spectrometry.
In this paper, we aim to bridge the advantage of in vivo DESI-MS and real-time classification of glioma subtypes.
Specifically, we show that machine learning techniques can be used to provide neurosurgeons with real-time information, which can be of critical importance for precise tumor resection. There exists a plethora of techniques for data classification. However, sparse kernel machines were chosen for their superior performance in dealing with highdimensional data [19] . Here, we consider two sparse kernel methods for glioma subtype classification, namely, support vector machines and relevance vector machines. We show that sparse kernel machines can be used for glioma subtype classification with a high accuracy.
II. SPARSE KERNEL MACHINES
In this section, we discuss two sparse kernel-based algorithms, namely, the support vector machine and the relevance vector machine. For a more comprehensive discussion on these methods, see [20] .
A. Support Vector Machine Algorithm
The support vector machine (SVM) algorithm [20] is a sparse kernel algorithm used in classification and regression problems. Here we will briefly discuss the SVM framework for the two-class classification problem. Let the training set be given by x 1 , x 2 , . . . , x N , with target values given by z 1 , z 2 , . . . , z N , respectively, where x n ∈ R D and z n ∈ {−1, 1}, n = 1, 2, . . . , N . Moreover, assume that this training set is linearly separable in a feature space R M defined by the transformation φ : R D → R M ; that is, there exists a linear decision boundary in the feature space separating the two classes.
To classify a new data point x ∈ R D by predicting its target value z define y(x) w T φ(x) + b, where w ∈ R M is a weight vector and b ∈ R is a bias parameter. This representation can be rewritten in terms of a kernel function as y(x) = N n=1 a n z n k(x, x n ) + b, where a n , n = 1, 2, . . . , N , and b are parameters determined by the training set x n and z n , n = 1, 2, . . . , N , and k(·, ·) is the kernel function. The sign of the function y(x) determines the class of x. More specifically, for a new data point x, the target value is given by z = sgn(y(x)), where sgn y y |y| , y = 0, and sgn(0) 0. In the SVM approach the parameters w and b are chosen such that the margin, that is, the minimum distance between the decision boundary and the data points, is maximized. Hence, only a subset of the training data (i.e., support vectors) is used to determine the decision boundary. It can be shown that the solution to the SVM problem results in a convex optimization problem [20] , and hence, a global optimum is guaranteed.
In the case where there is an overlap between the two data classes, the SVM algorithm can be modified by allowing misclassification of the data points. In this case, the margin is maximized while penalizing misclassified points. Such a trade-off is controlled by a positive complexity parameter C, which is determined using a hold-out method such as crossvalidation [20] .
B. Relevance Vector Machine Algorithm
The relevance vector machine (RVM) algorithm [21] is a Bayesian sparse kernel algorithm, which can be regarded as the Bayesian extension of the SVM algorithm.
Next, we briefly review the method for the classification problem involving two data classes, namely C 1 and C 2 . Let the training set be given by x 1 , x 2 , . . . , x N , with target values given by z 1 , z 2 , . . . , z N , where x n ∈ R D and z n ∈ {0, 1}, n = 1, 2, . . . , N , x n ∈ C 1 if z n = 1, and x n ∈ C 2 if z n = 0. For a new data point x ∈ R D , we predict the associated class membership posterior probability distribution, namely, p(C k |x), k = 1, 2, where p(C k |x) is the conditional probability of the data class C k given the data point x. The class membership posterior probability for a given data point x is given by
where φ :
In the sequel, we consider the general formulation (1). Each weight parameter w i , i = 1, . . . , M , in (1) is assumed to have a zero-mean Gaussian distribution, and hence, the weight prior distribution is given by
where α i , i = 1, 2, . . . , M , is the precision corresponding to the weight component
2 ) represents the normal distribution with mean µ and variance σ 2 . The parameters α i , i = 1, 2, . . . , M , in the prior distribution (3) are called the hyperparameters.
The hyperparameters α i , i = 1, 2, . . . , M , can be determined by maximizing the marginal likelihood distribution p(w|z, α), where z = [z 1 , z 2 , . . . z N ] T ∈ R N . As a result of the maximization of the marginal likelihood distribution, a number of the hyperparameters α i approach infinity. Thus, the corresponding weight parameter w i will be centered at zero, and hence, the corresponding component of the feature vector φ i (x) plays no role in the prediction, resulting in a sparse predictive model. For further details of this approach, see [20] , [21] .
III. GLIOMA TYPE CLASSIFICATION
In this section, we use the sparse kernel machines described in Section II to classify the subtype of a glioma sample. The data were collected from research subjects at the Brigham and Women's Hospital, Boston, MA. In this study, 28 glioma samples were acquired from multiple research subjects, where the samples were either astrocytomas (A) or oligodendrogliomas (O). For the purposes of maximizing spatial resolution, the scanning pattern shown in Figure 1 was used to analyze each sample [22] . In order to account for the chemical variation within a sample, numerous spectra were extracted from each sample (one spectrum from each scanned row). The number of spectra varied depending on the amount of usable tissue in the sample. In our data set, each sample contained between 7 to 45 spectra. A total of 19 astrocytoma samples and 9 oligodendroglioma samples were scanned, where the corresponding number of spectra was 426 and 205, respectively. To account for large-scale intensity differences between samples, each spectrum was normalized to zero mean and unit standard deviation. T ∈ R D , where s i = M S(m i ), i = 1, . . . , D, and s i is referred to as a feature point. For a given set of mass spectra {x 1 , . . . , x N }, x i ∈ R D , i = 1, . . . , N , the target value z i ∈ {0, 1}, i = 1, . . . , N , is provided by the pathologist, where z i = 0 (resp., z i = 1) indicates that x i was from an astrocytoma (resp., oligodendroglioma) sample.
The SVM and RVM frameworks were chosen for the classification problem, both with a linear kernel k(u, v) u T v, u, v ∈ R D . We applied the leave-one-out method for validation [20] . Specifically, one spectrum x j and its corresponding target value z j , j ∈ {1, . . . , N }, are excluded, and the remaining spectra and their corresponding target values are used as the training set. A class, y j , is assigned to x j using the trained model. This process is repeated for each spectrum, and the outputs are compared to the target values z j to determine the accuracy of the classifier.
The goal of cross-validation is to measure how well a classifier generalizes to a data set independent from the set used for training. As can be expected, the spectra extracted from the same sample exhibit a large degree of dependence. To compensate for this, spectra from the same sample as x j are also removed from the training set. Another issue was the difference in the number of spectra from each sample as discussed earlier in this section. This was remedied by trimming the training set to use the same number of spectra from each sample. This trimming, however, was carried out randomly, introducing some variation into the performance of cross-validation. Thus, cross-validation was repeated 10 times, and the accuracies were averaged in the results of Table I . The MATLAB implementation of SVM was used with the penalty C = 1. The MATLAB RVM library [23] was used for RVM classification. Table I shows the performance of the SVM and RVM for the problem of classifying mass spectra corresponding to astrocytoma and oligodendroglioma. Each row lists the sample number, the subtype determined by the pathologist (A for astrocytoma and O for oligodendroglioma), the percentage of the spectra in this sample that were properly classified using SVM and RVM. Comprehensive classification accuracies are listed at the bottom of each table, representing the percentage of all astrocytoma and oligodendroglioma spectra that were properly classified as well as the overall classification accuracy. These accuracies may be analyzed to identify samples that are given incorrect subtypes by the pathologists, or to identify samples that are chemically dissimilar to other samples in the same subtype. Finally, a feature selection technique was applied to the spectra. With thousands of points in the spectrum to describe two classes, redundancy in the information is expected [24] . Feature selection not only can improve the classification performance but also can aid in identifying the appropriate biomarkers for each glioma type. We implemented an iterative method of reducing the number of features [24] . The feature points were split into 10 subsets of size P ∈ Z + , {x 1 , . . . , x P }, {x P +1 , . . . , x 2P }, . . . , {x 9P +1 , . . . , x M }. The purpose was to identify the subset with the least effect on classification performance; these features were assumed to be either redundant or noisy, and were removed. The classification performance was measured by cross-validation, using an SVM classifier. This process was repeated iteratively, removing the features that contribute least to the classification performance in each iteration. A summary of these results are shown in Table II. As shown in Table II , the classification performance increases to 98% by selecting the most significant features. IV. CONCLUSION
In this paper, we proposed an approach for glioma subtype classification using mass spectrometry data. We considered two sparse kernel methods for glioma subtype classification, namely, SVM and RVM, and showed that sparse kernel machines can be used for glioma subtype classification with a high accuracy. Future work includes exploring alternative preprocessing, feature selection, and classification methods, extending this framework to the multi-class glioma classification problem as well as biomarker detection. Identifying the most significant molecules using a feature selection method can provide a deeper insight into the pathology of the condition and can improve treatment methods.
